These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12498508)
1. Choroidal effusion and shallowing of the anterior chamber after adjunctive therapy with latanoprost in a trabeculectomized patient with angle closure glaucoma. Alimgil ML; Benian O Int Ophthalmol; 2001; 24(3):129-31. PubMed ID: 12498508 [TBL] [Abstract][Full Text] [Related]
2. Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost. Krishnamurthy R; Senthil S; Garudadri CS BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26174734 [TBL] [Abstract][Full Text] [Related]
3. [Drug therapy for residual angle-closure glaucoma after laser iridectomy]. Wang N; Fan Z; Wu H; Li D; Huang Y; Chen J; Lin H Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):712-6. PubMed ID: 12654218 [TBL] [Abstract][Full Text] [Related]
4. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Sihota R; Saxena R; Agarwal HC; Gulati V Arch Ophthalmol; 2004 Feb; 122(2):185-9. PubMed ID: 14769594 [TBL] [Abstract][Full Text] [Related]
5. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients. Sakai H; Shinjyo S; Nakamura Y; Nakamura Y; Ishikawa S; Sawaguchi S J Ocul Pharmacol Ther; 2005 Dec; 21(6):483-9. PubMed ID: 16386090 [TBL] [Abstract][Full Text] [Related]
6. Choroidal detachment after the use of topical latanoprost. Marques Pereira ML; Katz LJ Am J Ophthalmol; 2001 Dec; 132(6):928-9. PubMed ID: 11730664 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study. Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840 [TBL] [Abstract][Full Text] [Related]
8. Choroidal effusion following laser peripheral iridotomy for the treatment of angle closure glaucoma in a patient with nanophthalmos. Thapa SS; Paudyal G Nepal Med Coll J; 2005 Jun; 7(1):81-2. PubMed ID: 16295732 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma. Chen MJ; Chen YC; Chou CK; Hsu WM J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247 [TBL] [Abstract][Full Text] [Related]
10. Latanoprost : an update of its use in glaucoma and ocular hypertension. Perry CM; McGavin JK; Culy CR; Ibbotson T Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627 [TBL] [Abstract][Full Text] [Related]
11. Four years later: a clinical update on latanoprost. Ravinet E; Mermoud A; Brignoli R Eur J Ophthalmol; 2003 Mar; 13(2):162-75. PubMed ID: 12696636 [TBL] [Abstract][Full Text] [Related]
12. Eyelid hypertrichosis associated with latanoprost is reversible. O'Toole L; Cahill M; O'Brien C Eur J Ophthalmol; 2001; 11(4):377-9. PubMed ID: 11820311 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma. Chen MJ; Chen YC; Chou CK; Hsu WM J Ocul Pharmacol Ther; 2006 Dec; 22(6):449-54. PubMed ID: 17238812 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials. Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA; Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045 [TBL] [Abstract][Full Text] [Related]